Vertex Pharmaceuticals
Company Details
Linkedin ID:
vertex-pharmaceuticals
Website:
Employees number:
6,124
Number of followers:
530,902
NAICS:
541714
Industry Type:
Homepage:
vrtx.com
IP Addresses:
81
Company ID:
VER_2771813
Scan Status:
Completed
Vertex Pharmaceuticals Company CyberSecurity Posture
vrtx.com
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases and have made significant advancements in multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continue to progress clinical and research programs in these diseases. We also have a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where we have deep insight into causal human biology, including acute and neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes, myotonic dystrophy type 1 and alpha-1 antitrypsin deficiency. Our global HQ is in Boston, and we have research and development (R&D) sites and commercial offices worldwide. Vertex is consistently recognized as one of the industry’s top places to work by Science Magazine, The Boston Globe, Boston Business Journal and the San Diego Business Journal. We have also earned a spot on TIME Most Influential Companies, TIME Best Inventions, and Fast Company Most Innovative Companies lists. Our research and medicines have received esteemed recognitions, including the Robert J. Beall Therapeutics Development Award, the Prix Galien, the Scrip Award and the Breakthrough Prize awards. Read our community guidelines: https://www.vrtx.com/vertexs-community-guidelines/
Vertex Pharmaceuticals A.I CyberSecurity Scoring
Vertex Pharmaceuticals Risk Score (AI oriented)Between 750 and 799
Vertex Pharmaceuticals
Updated:
- Powered by our proprietary A.I cyber incident model
- Insurance preferes TPRM score to calculate premium
Vertex Pharmaceuticals Global Score (TPRM)XXXX
Vertex Pharmaceuticals
- Instant access to detailed risk factors
- Benchmark vs. industry & size peers
- Vulnerabilities
- Findings
Vertex Pharmaceuticals Company CyberSecurity News & History
Past Incidents
0
Attack Types
0
No data available
Vertex Pharmaceuticals Company Scoring based on AI Models
Cyber Incidents Likelihood 3 - 6 - 9 months
A.I Risk Score Likelihood 3 - 6 - 9 months
Underwriter Stats for Vertex Pharmaceuticals
Incidents vs Biotechnology Research Industry Average (This Year)
No incidents recorded for Vertex Pharmaceuticals in 2025.
Incidents vs All-Companies Average (This Year)
No incidents recorded for Vertex Pharmaceuticals in 2025.
Incident Types Vertex Pharmaceuticals vs Biotechnology Research Industry Avg (This Year)
No incidents recorded for Vertex Pharmaceuticals in 2025.
Incident History — Vertex Pharmaceuticals (X = Date, Y = Severity)
Vertex Pharmaceuticals cyber incidents detection timeline including parent company and subsidiaries
Vertex Pharmaceuticals Company Subsidiaries
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases and have made significant advancements in multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continue to progress clinical and research programs in these diseases. We also have a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where we have deep insight into causal human biology, including acute and neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes, myotonic dystrophy type 1 and alpha-1 antitrypsin deficiency. Our global HQ is in Boston, and we have research and development (R&D) sites and commercial offices worldwide. Vertex is consistently recognized as one of the industry’s top places to work by Science Magazine, The Boston Globe, Boston Business Journal and the San Diego Business Journal. We have also earned a spot on TIME Most Influential Companies, TIME Best Inventions, and Fast Company Most Innovative Companies lists. Our research and medicines have received esteemed recognitions, including the Robert J. Beall Therapeutics Development Award, the Prix Galien, the Scrip Award and the Breakthrough Prize awards. Read our community guidelines: https://www.vrtx.com/vertexs-community-guidelines/
Loading...
Vertex Pharmaceuticals Similar Companies
Amgen
Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s
Charles River Laboratories
At Charles River, we are guided by our strong purpose—to create healthier lives—which centers around the patients who rely on the therapeutics we help to develop, the animals in our care, to our planet, and to the passionate and skilled people who are at the heart of our organization and make it all
At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy healt
Avantor® is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development an
Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality
bioMérieux
A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide. Since 1963, we've been paving the way in the field of in v
About Genentech We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions. That is why we use cutting-edge science to create and deliver innovative medicines around the globe. To us, science is personal. Making a difference in the lives of millions s
CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our pr
Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 60 countries, operating over 950 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to eva
.png)
Vertex Pharmaceuticals CyberSecurity News
November 14, 2025 06:47 PM
About Us - Great American Insurance Group - Specialty Property & Casualty Insurance
The global financial markets are in the midst of a profound transformation, driven by an accelerating wave of technological advancements.
October 25, 2025 07:00 AM
Vertex Pharmaceuticals Stock Forecast: Where Analysts See the Stock Going by 2027
Here's why analysts believe Vertex Pharmaceuticals (NASDAQ: VRTX) stock could see about 22% upside by 2027, driven by strong margins,...
March 21, 2025 07:00 AM
Why CFOs and CIOs are in a power struggle over AI
Good morning. CFOs and chief information officers (CIOs) steer technology to meet business needs. That also means justifying large AI...
February 21, 2025 08:00 AM
Cyril Amarchand Mangaldas guides Vertex Ventures in $16 Million Series A funding for AI platform Spyne
Cybersecurity: Vertex Ventures, with Cyril Amarchand Mangaldas as their legal advisor, led a Series A funding round, raising USD 16 million...
December 21, 2024 08:00 AM
My Top 10 Stocks to Buy for 2025
Here are my top 10 buys -- in no particular order -- for 2025 and beyond. Most of these stocks have a solid earnings track record.
September 05, 2024 07:00 AM
Five reasons to dive into our Tech Trends Outlook
Our newest Technology Trends Outlook offers a pragmatic, holistic, and highly readable view of the technologies that are shaping our lives.
July 31, 2024 07:00 AM
FDA accepts NDA for Vertex’s non-opioid pain drug
Vertex Pharmaceuticals revealed that the FDA has accepted its NDA for suzetrigine, a non-opioid pain inhibitor.
May 20, 2024 07:00 AM
Fenwick Represents Alpine Immune Sciences in its Acquisition by…
Vertex acquired all the outstanding shares of Alpine for $65 per share, for an aggregate value of approximately $4.9 billion.
November 28, 2023 08:00 AM
Article | What to know about looming FDA decision on first gene-editing therapy
The FDA will soon decide whether to approve a first-in-class, one-time gene-editing treatment to potentially cure a rare genetic blood...
Frequently Asked Questions
Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
Vertex Pharmaceuticals CyberSecurity History Information
Official Website of Vertex Pharmaceuticals
The official website of Vertex Pharmaceuticals is https://www.vrtx.com/.
Vertex Pharmaceuticals’s AI-Generated Cybersecurity Score
According to Rankiteo, Vertex Pharmaceuticals’s AI-generated cybersecurity score is 763, reflecting their Fair security posture.
How many security badges does Vertex Pharmaceuticals’ have ?
According to Rankiteo, Vertex Pharmaceuticals currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
Does Vertex Pharmaceuticals have SOC 2 Type 1 certification ?
According to Rankiteo, Vertex Pharmaceuticals is not certified under SOC 2 Type 1.
Does Vertex Pharmaceuticals have SOC 2 Type 2 certification ?
According to Rankiteo, Vertex Pharmaceuticals does not hold a SOC 2 Type 2 certification.
Does Vertex Pharmaceuticals comply with GDPR ?
According to Rankiteo, Vertex Pharmaceuticals is not listed as GDPR compliant.
Does Vertex Pharmaceuticals have PCI DSS certification ?
According to Rankiteo, Vertex Pharmaceuticals does not currently maintain PCI DSS compliance.
Does Vertex Pharmaceuticals comply with HIPAA ?
According to Rankiteo, Vertex Pharmaceuticals is not compliant with HIPAA regulations.
Does Vertex Pharmaceuticals have ISO 27001 certification ?
According to Rankiteo,Vertex Pharmaceuticals is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
Industry Classification of Vertex Pharmaceuticals
Vertex Pharmaceuticals operates primarily in the Biotechnology Research industry.
Number of Employees at Vertex Pharmaceuticals
Vertex Pharmaceuticals employs approximately 6,124 people worldwide.
Subsidiaries Owned by Vertex Pharmaceuticals
Vertex Pharmaceuticals presently has no subsidiaries across any sectors.
Vertex Pharmaceuticals’s LinkedIn Followers
Vertex Pharmaceuticals’s official LinkedIn profile has approximately 530,902 followers.
NAICS Classification of Vertex Pharmaceuticals
Vertex Pharmaceuticals is classified under the NAICS code 541714, which corresponds to Research and Development in Biotechnology (except Nanobiotechnology).
Vertex Pharmaceuticals’s Presence on Crunchbase
No, Vertex Pharmaceuticals does not have a profile on Crunchbase.
Vertex Pharmaceuticals’s Presence on LinkedIn
Yes, Vertex Pharmaceuticals maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/vertex-pharmaceuticals.
Cybersecurity Incidents Involving Vertex Pharmaceuticals
As of December 11, 2025, Rankiteo reports that Vertex Pharmaceuticals has not experienced any cybersecurity incidents.
Number of Peer and Competitor Companies
Vertex Pharmaceuticals has an estimated 4,470 peer or competitor companies worldwide.
Vertex Pharmaceuticals CyberSecurity History Information
How many cyber incidents has Vertex Pharmaceuticals faced ?
Total Incidents: According to Rankiteo, Vertex Pharmaceuticals has faced 0 incidents in the past.
What types of cybersecurity incidents have occurred at Vertex Pharmaceuticals ?
Incident Types: The types of cybersecurity incidents that have occurred include .
Incident Details
What are the most common types of attacks the company has faced ?
Additional Questions
.png)
Latest Global CVEs (Not Company-Specific)
Description
FreePBX Endpoint Manager is a module for managing telephony endpoints in FreePBX systems. Versions prior to 16.0.96 and 17.0.1 through 17.0.9 have a weak default password. By default, this is a 6 digit numeric value which can be brute forced. (This is the app_password parameter). Depending on local configuration, this password could be the extension, voicemail, user manager, DPMA or EPM phone admin password. This issue is fixed in versions 16.0.96 and 17.0.10.
Risk Information
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description
Neuron is a PHP framework for creating and orchestrating AI Agents. In versions 2.8.11 and below, the MySQLWriteTool executes arbitrary SQL provided by the caller using PDO::prepare() + execute() without semantic restrictions. This is consistent with the name (“write tool”), but in an LLM/agent context it becomes a high-risk capability: prompt injection or indirect prompt manipulation can cause execution of destructive queries such as DROP TABLE, TRUNCATE, DELETE, ALTER, or privilege-related statements (subject to DB permissions). Deployments that expose an agent with MySQLWriteTool enabled to untrusted input and/or run the tool with a DB user that has broad privileges are impacted. This issue is fixed in version 2.8.12.
Risk Information
cvss3
Base: 9.4
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H
Description
Neuron is a PHP framework for creating and orchestrating AI Agents. Versions 2.8.11 and below use MySQLSelectTool, which is vulnerable to Read-Only Bypass. MySQLSelectTool is intended to be a read-only SQL tool (e.g., for LLM agent querying, however, validation based on the first keyword (e.g., SELECT) and a forbidden-keyword list does not block file-writing constructs such as INTO OUTFILE / INTO DUMPFILE. As a result, an attacker who can influence the tool input (e.g., via prompt injection through a public agent endpoint) may write arbitrary files to the DB server if the MySQL/MariaDB account has the FILE privilege and server configuration permits writes to a useful location (e.g., a web-accessible directory). This issue is fixed in version 2.8.12.
Risk Information
cvss3
Base: 8.2
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:N
Description
Okta Java Management SDK facilitates interactions with the Okta management API. In versions 11.0.0 through 20.0.0, race conditions may arise from concurrent requests using the ApiClient class. This could cause a status code or response header from one request’s response to influence another request’s response. This issue is fixed in version 20.0.1.
Risk Information
cvss3
Base: 8.4
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:H/I:H/A:L
Description
The Auth0 Next.js SDK is a library for implementing user authentication in Next.js applications. When using versions 4.11.0 through 4.11.2 and 4.12.0, simultaneous requests on the same client may result in improper lookups in the TokenRequestCache for the request results. This issue is fixed in versions 4.11.2 and 4.12.1.
Risk Information
cvss3
Base: 5.4
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:R/S:U/C:H/I:L/A:N
Access Data Using Our API
Get company history
curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?linkedin_id=vertex-pharmaceuticals' -H 'apikey: YOUR_API_KEY_HERE'
RapidWhat Do We Measure ?
Incident
Finding
Grade
Digital Assets
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
These are some of the factors we use to calculate the overall score:
Network Security
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
SBOM (Software Bill of Materials)
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
CMDB (Configuration Management Database)
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Threat Intelligence
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.
